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Highlights 
 
• Less than 15% of rats display diagnostic criteria of uncontrolled alcohol seeking  
• These vulnerable rats have reduced striatal dopamine 2 receptor expression 
• And increased striatal dopamine 1 receptor expression 
• Significant correlations were observed between microbiome and dopamine 
receptors 
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Abstract 
Identifying biological markers predicting vulnerability to develop excessive alcohol 
consumption may lead to a real improvement of clinical care.  With converging evidence 
suggesting that gut microbiome is capable of influencing brain and behavior, this study 
aimed at investigating whether changes in gut microbiome composition is associated 
with conditioned responses to alcohol. We trained Wistar rats to self-administer alcohol 
for a prolonged period before screening those exhibiting uncontrolled alcohol seeking 
and taking by modeling diagnostic criteria for AUD: inability to abstain during a signaled 
period of reward unavailability, increased motivation assessed in a progressive effortful 
task and persistent alcohol intake despite aversive foot shocks. Based on addiction 
criteria scores, rats were assigned to either Vulnerable or Resilient groups. Vulnerable 
rats not only displayed increased impulsive and compulsive behaviors, but also 
displayed increased relapse after abstinence and increased sensitivity to baclofen 
treatments compared to resilient animals. Then, rats underwent a 3-month wash out 
period before sacrifice. Dorsal striatum was collected to assess dopamine receptor 
mRNA expression, and 16S microbiome sequencing was performed on caecal contents. 
Multiple significant correlations were found between gut microbiome and impulsivity 
measures, as well as augmentations in striatal Dopamine 1 receptor (D1R) and 
reductions in D2R as vulnerability to AUD increased. Therefore, using a singular 
translational approach based on biobehavioral dispositions to excessive alcohol seeking 
without heavy intoxication, our observations suggests an association between gut 
microbiome composition and these specific “at risk” behavioral traits observed in our 
translationally relevant model.   
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1. Introduction 
Unhealthy alcohol use is one of the world’s leading causes of death and diseases. 
Recent reports underline that approximately 3.3 million deaths worldwide and 139 
million disability adjusted life years are attributed to alcohol use (World Health 
Organization, 2014). Besides this unacceptable human cost, alcohol use disorder (AUD) 
represents a growing economic burden worldwide, total cost of which is estimated in the 
range of US$ 200-700 billion annually, both in Europe and in the United States (Barrio 
et al., 2017; Baumberg, 2006; Sacks et al., 2015). Reduction of heavy drinking and 
relapse prevention currently represent the main therapeutic objectives in the treatment 
of alcohol use disorder, but the ratio of good responders remains much too low to be 
satisfying (Mann and Hermann, 2010). Therefore, alternative approaches should be 
privileged. One strategy would consist of better identifying "problem drinkers" in the 
general population who are not yet manifesting major symptoms of heavy intoxication 
but are drinking at levels that increase risks for medical and psychosocial 
consequences (Saitz, 2009). Growing evidence points out to a role of the microbiota-
gut-brain axis in AUD, with excessive ethanol consumption altering the gut microbiome, 
increasing the intestinal permeability and exacerbating systemic inflammation, ultimately 
amplifying comorbidities classically observed in alcoholic patients (Bull-Otterson et al., 
2013; de Timary et al., 2015; Gorky and Schwaber, 2016; Leclercq et al., 2017, 2014a, 
2014b, 2012; Temko et al., 2017).  
Recent observations have begun to shed light on the inextricable connection 
between microbes and mammals, leading to the provocative postulate that humans 
would not have developed the current level of cognitive performance in absence of 
bacteria (Cryan and Dinan, 2012; Dinan et al., 2015; Montiel-Castro et al., 2013; 
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Sampson and Mazmanian, 2015). In support of this assertion, a current consensus has 
now established how the commensal microbiota of the intestine greatly influence all 
aspects of physiology, including a fine tuning of brain function and behavior (Doherty et 
al., 2017; Hoban et al., 2017). With the intestinal microbiome collectively encoding more 
than 3.3 million of non-redundant genes (Qin et al., 2010), exceeding by far the number 
encoded by the human host genome, large-scale metagenomic projects have 
endeavored to unveil the contribution of gut microbes to the unconscious system 
regulating behavior. In this perspective, there is a growing appreciation of the role of the 
gut microbiome in regulating brain and behavior, in health and disease (Dinan and 
Cryan, 2017, Sherwin et al, 2017). Overall, the microbiota–gut–brain axis helps 
maintaining homeostasis of the brain by controlling central physiological processes 
including neurotransmission, neurogenesis, neuroinflammation and neuroendocrine 
signaling (Clarke et al., 2014).  
In particular, recent reports suggest that alcohol exposure triggers neuroimmune and 
inflammatory processes in the brain (Crews et al., 2017a, 2017b, 2013). Although the 
source of this neuroinflammation is not yet understood, growing evidence suggests that 
alterations in microbiota composition may contribute to neuroimmune processes and 
peripheral inflammation (de Timary et al., 2015; Gorky and Schwaber, 2016; Rea et al., 
2016). Changes in the gut microbiome have been reported in both human alcoholic 
individuals and murine models of chronic alcohol exposure, with increased intestinal 
permeability (causing endotoxin to escape into the circulation and impact the host), 
increased abundance of pro-inflammatory gut microbes, like Proteobacteria species, 
and decreased abundance of normal commensal bacteria like Bacteroidetes (Bull-
Otterson et al., 2013; Leclercq et al., 2017; Mutlu et al., 2012; Peterson et al., 2017). 
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However, if chronic excessive alcohol use seems to significantly impact the microbiota, 
it does not seem to be sufficient to cause gut dysfunction in all alcohol dependent 
patients, since altered microbiota composition was reported in only a subset of 
alcoholics. Further, alterations in microbial composition were not correlated to the 
duration of sobriety, suggesting alcohol-related dysbiosis is long-lasting and persists 
despite abstinent periods (Leclercq et al., 2017, 2014a, 2014b, 2012; Mutlu et al., 
2012). Meanwhile, gut microbial and peripheral metabolite level alterations remain 
narrowly linked to alcohol craving, anxiety, and depression, considered important 
personality traits associated with the vulnerability to develop AUD (de Timary et al., 
2015; Leclercq et al., 2014a, 2014b, 2012).  
The inability to control drug taking in general, and conditioned responses in 
particular, is a complex brain disorder that affects the most vulnerable individuals and 
worsens with recurring drug consumption. Therefore, understanding the heterogeneity 
in the behavioral characteristic of patients with AUD is warranted for developing 
personalized treatments. We recently claimed that most preclinical studies still defend 
pharmacology-centered views that do not really capture the inter-individual vulnerability 
to lose control over alcohol consumption (Jadhav et al., 2017). Considering that 
preclinical investigations about genetic/temperament predisposition to alcohol abuse 
require the development of an appropriate and relevant animal model, we adapted to 
rodents a few criteria used for screening AUD according to the DSM and contributed to 
recognize that addiction is a progressive and idiosyncratic disorder. The recent reports 
suggesting that personality traits associated with risk for drug addiction may be linked to 
the microbiome-gut-brain axis (Bravo et al., 2011; Collins et al., 2013; Golubeva et al., 
2017; McVey Neufeld et al., 2016) calls for further investigation to determine whether 
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gut microbiome diversity and composition may be associated with behaviors related to 
alcohol use disorders.  
To this end, we assessed microbiota composition was different in rats exhibiting a 
biobehavioral disposition to lose control over alcohol consumption by comparison with 
resilient animals. Moreover, we sought to investigate of changes in the microbiome 
correlated with alterations in striatal dopamine receptor levels that may underlie the 
observed behavioural changes in the rat model of AUD.  
 
2. Material and methods 
 
2.1. Animals 
Male Wistar rats were bred in-house at the Center for Psychiatric Neuroscience 
animal facility (breeders ordered from Charles River, France). They were approximately 
7 weeks old and weighed 200–250 grams at the beginning of the experiment. They 
were kept in reversed 12-h light/dark cycle (lights off at 8.30 am) and housed in 
controlled temperature and humidity conditions. All experiments were performed in 
accordance with the Swiss Federal Act on Animal Protection and the Swiss Animal 
Ordinance and were approved by the cantonal veterinary office (authorization 3047 to 
B.B). 
 
2.2. Behavioral phenotyping of alcohol use disorder 
The procedure for screening addiction-like behaviors has been extensively described 
elsewhere (Jadhav et al., 2017). Briefly, rats were first monitored for assessing 
impulsive behaviors using a 5-choice serial reaction time task paradigm (5-CSRTT). 
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They were then tested in an elevated plus maze for measuring their anxiety-like 
behaviors. Then, rats were daily trained for 30 min to self-administer 0.1 ml of alcohol 
10% weight/volume for 80 consecutive sessions, before being screened for addiction-
like behavior (see supplementary information for further detail). Test sessions aiming at 
identifying rats at risk of losing control over alcohol intake operationalized 3 diagnostic 
criteria for AUD: inability to abstain during a signaled period of reward unavailability, 
increased motivation assessed in a progressive effortful task and persistent alcohol 
intake despite aversive foot shocks. Each rat was considered positive for one addiction-
like criterion if its score reached the 66th-99th percentile of the total distribution. The 
addiction score was calculated as the sum of the standardized scores of each of the 
addiction-like criteria (Deroche-gamonet et al., 2004). A total of 60 rats were trained (1 
outlier exhibiting very high lever pressing behavior was excluded), with those identified 
as positive for 2-3 criteria, defined as Vulnerable were grouped together (N=19), and 
those with 0 and 1 criterion grouped and named Resilient (N=40). To further validate our 
model, rats were first exposed to a conflict situation in which they had to bear electrical 
foot shocks prior to get access to ethanol. Second, we tested baclofen responses in 
both groups of rats in order to assess whether the reinforcing and motivational 
properties of alcohol in resilient and vulnerable rats were differentially sensitive to an 
anti-alcohol effect treatment. Further details on the behavioral procedure are provided in 
Supplementary Information.  
 
2.3. Ceacal microbiome collection and sequencing 
All samples from the Vulnerable group (N=19) and an equivalent subset from 
Resilient group (N=19) were used for microbiome analysis. The selected Vulnerable rats 
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belonged to the top 33% of the population for the three behaviors and the Resilient rats 
belonged to the lowest 33% of the population. Caecum was collected following three 
months of abstinence under aseptic conditions and snap-frozen on dry ice. Protocols for 
microbiome sequencing were used as previously described (Peterson et al., 2017). 
Briefly, caecal contents from frozen caecum (stored at -80ºC) was extracted under a 
sterile hood. The QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) was used to 
extract bacterial DNA from caecal contents using the manufacturer’s handbook (Second 
Edition 2012) Isolation of DNA from Stool for Pathogen Detection protocol. Samples 
were prepared for 16S sequencing using the Nextera XT DNA Library Prep Kit (Illumina, 
San Diego, CA, USA), as described in the Illumina 16S library preparation workflow. 
16S bacterial rRNA gene was amplified using primers targeting the V3-V4 hypervariable 
region (Forward: 5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGN 
GGCWGCAG; 
Reverse:5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACT 
ACHVGGGTATCTAATCC) (Sigma Aldrich Ireland ltd., Wicklow, Ireland). The 
Illumina V3–V4 primers were selected for their high coverage (94.5% bacteria) while 
remaining in the amplicon size necessary for sequencing (Klindworth et al., 2013). 16S 
rRNA amplicons were sequenced on the Illumina MiSeq platform (Teagasc, Morrepark, 
Ireland). 
 
2.4. Microbiome Sequence Processing 
Sequence reads in FASTQ files were joined using FLASH and analyzed with QIIME 
(Quantitative Insights Into Microbial Ecology, v1.9.1). Sequence quality was checked, 
and chimeras removed, remaining sequences were clustered into Operational 
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Taxonomic Units (OTUs) using USEARCH (Version 7.0-64bit). The average number of 
high-quality sequences generated per sample was 150,707 ± 69,666 SD. Taxonomy 
was assigned to OTUs using Silva version 123. Alpha diversity indices were calculated 
with Qiime.  
 
2.5. Gene expression analysis 
Samples from 0Crit (N=8) and 3Crit (N=7) group were selected for gene expression 
analysis. Whole brains were extracted and rapidly sliced into 2 mm-thick coronal 
sections in a rat brain stainless steel matrix. Slices containing dorsal striatum were used 
for micro-punch dissection (0.98 mm diameter micro-punch, Stoelting, Dublin, Ireland). 
RNA was extracted with a RNeasy Plus Minikit (Qiagen, Valencia, CA, USA) and 
converted into cDNA by reverse transcription reaction using TaqMan Reverse 
Transcriptase Reagents (Applied Biosystem, Foster City, CA, USA). Real-time PCR 
amplification was performed with an ABIPRISM 7500 cycler and SYBER green PCR 
Master Mix (Applied Biosystem, Foster City, CA, USA) using specific sets of primers 
(Microsynth AG, 9436 Balgach, Switzerland). Forward and reverse primers for the 
tested genes are the following: β-actin = forward: 5′-GCTTCTTTGCAGCTCCTTCGT-3′, 
reverse: 5′-ATATCGTCATCCATGGCGAAC-3′; D1 receptor = forward: 5’-
GGAGGACACCGAGGATGA-3’, reverse: 5’-ATGAGGGACGATGAAATGG-3’, D2 
receptor = forward: 5’-TGGGTCAGAAGGGAAGG-3’, reverse: 5’-
GATGATAAAGATGAGGAGGGT-3’.  All samples were analyzed in triplicates. Relative 
gene expression was measured with the comparative ΔΔCt method24 and normalized 
with β-actin transcript levels. 
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2.6. Statistical Analysis 
For behavioral & mRNA Analysis, data was tested for normality (Shapiro-Wilks test) 
and equality of variances (Levene’s Test). Data are expressed as mean ± standard 
error (SE). Parametric data were analyzed by one way- and two-way ANOVAs followed 
by Bonferroni corrections, respectively. Homoscedastic, parametric measures were 
evaluated with two sample T-test. Unpaired T test was used to analyze the anxiety data. 
Nonparametric measures were evaluated with Mann–Whitney test. Baclofen response 
was calculated with a Wilcoxon sign-ranks test. The level of significance was set at 
0.05, and analyses were performed using IBM SPSS Statistics 23. 
Microbiota analysis was performed in R (v3.3.3) and RStudio (v1.0.136). Plots were 
generated in R using ggplot2 package (v2.2.1). Mann–Whitney test was used to assess 
statistical significance in alpha diversity indices and taxonomic comparisons between 
groups. Beta diversity was visualized and analyzed by OTU counts normalized using 
the wisconsin function from vegan community ecology package (v2.4-3). Adonis 
(PERMANOVA, permutations=999) vegan function assessed beta diversity significance 
between groups. Spearman correlation was performed on genus and family level 
bacterial abundance, behavioral measures, and dopamine receptor mRNA relative-
expression levels. Since dopamine mRNA expression data was only available for 15 
subjects, correlations to microbiome only included these 15 subjects. In all other 
behaviour correlations, all samples were used (N=38). All correlations and taxonomic 
comparisons were corrected for multiple testing using the q value (v2.6.0) R package, 
with the critical value for false discovery rate (Q) set at 0.10. Log2 fold ratio calculated 
mean genus-level change in abundance for the Vulnerable group relative to Resilient 
group. 
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3. Results 
3.1. Identification of rats at risk of alcohol use disorder 
 
After 80 sessions of operant conditioning (fixed ratio 1, time out 4 sec to get 0.1 mL 
of 10% w/v ethanol, Figure 1A), rats underwent a procedure for screening evidence for 
addiction-like behavior. A rat was considered positive for an addiction-like criterion when 
its score was in the 66th to 99th percentile of the distribution. Hence, of the total 59 rats, 
we obtained 4 groups, 26 rats with 0 criterion, 14 rats with 1 criterion, 12 rats with 2 
criteria and 7 rats with 3 criteria (Figure 1B).  
One-way ANOVAs revealed significant differences in the inability to abstain during a 
signaled period of reward unavailability (F3,55 = 17.436, p < 0.0001, Figure 1C), in the 
motivation to seek for ethanol in a progressive effortful task (F3,55 = 23.23, p < 0.0001, 
Figure 1D), in the persistence in ethanol seeking despite aversive foot shocks 
(F3,55 = 22.55, p < 0.0001, Figure 1E), and finally in the vulnerability to relapse after a 
period of abstinence (F3,55=6.13, p=0.0012, Figure 1G).  Further statistical analyses are 
provided in Supplementary Information. 
The addiction scores, calculated as the sum of the standardized scores of each of the 
addiction-like criteria, were significantly different from each other (F3,55 = 67.20, 
p<0.0001), and were linearly increasing from 0crit to 3crit rats (Figure 1 F). We therefore 
clubbed 0 and 1 crit rats together and named them Resilient, while 2 and 3 crit rats were 
grouped and named Vulnerable. 
Further statistical analyses (available in the Supplementary Information) showed 
increased compulsive behavior and increased sensitivity to baclofen treatments (Figure 
1 H, I and J), as well as increased predisposing impulsivity (Figure 1K) in Vulnerable 
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rats compared to Resilient ones. Ultimately, factor analysis revealed that the three 
addiction-like criteria, the reinstatement and the pre-existing trait of impulsivity loaded 
on one construct accounting for 50% of the variance, and therefore measuring one 
single underlying factor. Overall, these series of observations served as a strong 
rationale for identifying rats with a loss of control-prone phenotype, without heavy 
ethanol intoxication given their history of brief exposures to alcohol used in this 
procedure. 
 
3.2. Behavioral profiling of selected resilient and vulnerable rats 
 
Nineteen Resilient (eighteen 0Crit and one 1Crit rats) and nineteen Vulnerable 
(twelve 2Crit and seven 3Crit rats) animals among the 59 rats initially screened were 
selected for microbiome analyses (see supplementary information).  A brief presentation 
of their respective behaviors is summarized on Figure 2. 
Vulnerable rats exhibited increased alcohol seeking behaviors, in the presence of 
shock (Mann–Whitney U = 14, p<0.001, Figure 2A) and absence of ethanol (Mann–
Whitney U = 15, p<0.001, Figure 2B), and increased motivation assessed in a 
progressive ratio schedule of reinforcement (Mann–Whitney U = 11, p<0.001, Figure 
2C). Addiction score and reinstatement of a lever pressing behavior after a period of 
abstinence were significantly higher in Vulnerable rats compared to Resilient (Mann–
Whitney U = 0, p<0.001, Figure 2D and T-Test t(36)=-4.50, p<0.001, Figure 2E, 
respectively). Vulnerable rats’ response to baclofen treatment (1mg/kg) was enhanced, 
with a breaking point for ethanol seeking significantly reduced compared to resilient rats 
(Mann–Whitney Z=-2.24, p<0.05, Figure 2F). 
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Vulnerable rats exhibited enhanced motor impulsivity, reflected by the percentage of 
premature responses in a 5-choice serial-reaction time task (T-test t(36)=-2.74, p<0.01, 
Figure 3A). They did not display any anxiety-like behavior on the elevated plus maze 
(Mann–Whitney U = 136, p>0.05, Figure 3B), but increased novelty induced locomotor 
activity (Mann–Whitney U = 99, p<0.05, Figure 3C) compared to resilient animals.  
Total ethanol consumed over the entire 80 self-administration sessions was analyzed 
for subjects used in microbiome analysis.  There was no significant difference between 
groups (t(36)=-1.73, p>0.05). Although the Vulnerable group had significantly higher 
body weight compared to Resilient (t(36)=-2.38, p<0.05), cecum weight was not 
significantly different between groups (t(36)=0.40, p>0.05). 
Finally, given the importance of the dopaminergic system in the striatum and the 
pivotal role it plays in the reward circuitry, we investigated the expression of the D1 
receptor and D2 receptor in the dorsal striatum. D1 receptor expression was 
significantly higher (t(13)=-2.88, p<0.05) and D2 receptor expression significantly lower 
in the Vulnerable group (t(13)=5.54, p<0.001)  compared to Resilient group (Figure 3E-
F). 
 
3.3. 16S microbiome analyses in caecal contents of resilient and vulnerable rats 
 
3.3.1. Alpha and Beta Diversity 
Alpha and beta diversity analysis revealed no significant difference between 
Vulnerable and Resilient group, but a trend towards increased richness and evenness in 
the Vulnerable group (Figure 4A-B). 
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3.3.2. Taxa Level Relative Abundance 
Compositional comparisons at the phylum, family, and genus level showed no 
significant difference between Vulnerable and Resilient group after False Discovery 
Rate (FDR) correction (p>0.05). At phylum level, a trend towards increased Firmicutes 
and decreased Actinobacteria in Vulnerable group (p>0.05) were seen. Comparisons at 
the family level revealed trends of increased Ruminococcaceae and decreased 
Bacillales Family.XI and Deferribacteraceae in Vunerable group. Additionally, changes 
in many genera of Lachnospiraceae and Ruminococcaceae were observed, however 
did not pass FDR significance testing (p>0.05) (Figure 5). 
 
3.3.3.  Microbiome, Behaviour, and mRNA expression Correlation Analysis 
The strongest correlations were seen between D2R mRNA expression and low 
abundance bacteria belonging to phylum Firmicutes (|rho|>0.55, p<0.05), comprised 
mainly of positive correlations. The largest decrease in Vulnerable relative to Resilient 
group was observed in genus Veillonella (log2 ratio=-4.6), which was negatively 
correlated to D1R mRNA expression (rho<-0.58, p<0.05). Other significant correlations 
to D1R mRNA expression include genera Gemella (rho<-0.61, p<0.05), and two from 
family Ruminococcaceae (rho<-0.57, p<0.05) (Figure 6).  
AUD behaviour showed a significate positive correlation to bacteria in order 
Clostridiales (rho>0.35, p<0.05), including many genera from family Ruminococcaceae 
and Lachnospiraceae. Significant, negative correlations were seen between AUD 
behaviour and genera Desulfovibrio (rho<-0.45, p<0.01), Gemella (rho<-0.43, p<0.01), 
uncultured Coriobacteriaceae (rho<-0.40, p<0.05), and Hydrogenoanaerobacterium 
(rho<-0.36, p<0.05). The 5-Choice Serial Reaction Time Task measure of impulsivity 
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showed significant positive correlations to two genera of Lachnospiraceae (rho>0.34, 
p<0.05), Lachnospiraceae uncultured and Lachnospiraceae UCG-005, and significant 
negative correlation to bacteria in family Ruminococcoceae (rho<-0.35, p<0.05), an 
uncultured bacterium in the Eubacterium coprostanoligenes group. Anxiety measures 
(percentage time on open arms) from the EPM test were significantly positively 
correlated to the genus level bacteria Lachnospiraceae UCG-006 (rho>0.41, p<0.01) 
and Papillibacter (rho>0.34, p<0.05), in family Ruminococcoceae. On the other hand, 
EPM anxiety measure was negatively correlated to genus Anaerofilum (rho<-0.42, 
p<0.01), in family Ruminococcoceae. OFT measure of novelty induced locomotion 
negatively correlated to genera Lachnospiraceae UCG-007 (rho<-0.44, p<0.01) and an 
uncultured bacterium in the Ruminococcoceae Eubacterium coprostanoligenes group 
(rho<-0.40, p<0.05). Total ethanol (EtOH) consumption (TotEtOH) significantly 
correlated with Gemella (rho<-0.37, p<0.05) (Figure 6).  
Most correlations are seen in low abundance bacteria (mean abundance < 0.001%) 
however most of these low abundance genus level bacteria are present in the majority 
of samples (Supplementary Table 4). At the family level, Bacillales Family XI is most 
frequently correlated to behaviour measures. Both at the genus and family level this 
bacterium is in very low abundance and only present in 9 of the 38 samples. Family 
level correlations, relative abundance and presence in samples of bacteria correlating to 
addiction measures is listed in Supplementary Tables 3-6.  
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4. Discussion 
A link between alterations in microbiota and alcohol-related behavioural changes has 
remained relatively unexplored. Here we show for what is to our knowledge the first time 
microbiota composition is associated to addiction measures in a realistic model of AUD. 
Moreover, low abundance bacteria coincided with changes in central gene expression. 
Converging evidence suggests that for some alcoholics (probably 30–50% of the 
total), ethanol consumption alters the gut microbiome by depleting protective bacteria, 
increasing intestinal permeability and releasing inflammation factors like bacterial 
peptidoglycans and lipopolysaccharide, which ultimately amplifies the psychopathology 
of alcoholism (de Timary et al., 2017, 2015; Gorky and Schwaber, 2016; Leclercq et al., 
2014a, 2014b, 2012). However, authors suggested that alterations in microbiota 
composition could be responsible for the ‘leaky gut’ upon alcohol consumption, as no 
increase in permeability was observed in alcoholic patients which were resilient to 
microbiota changes, despite their alcohol consumption (de Timary et al., 2015). With 
alterations in microbial composition reported in only a subset of alcoholic patients and 
not correlated to the duration of sobriety, alcohol-related microbial imbalance is 
considered a long-lasting consequence that persists despite abstinent periods (Mutlu et 
al., 2012). Also, personality traits associated with the vulnerability to develop AUD have 
been consistently linked to gut microbial and peripheral metabolite level alterations. In 
particular, alcoholic patients without overt microbiota disturbances showed less severe 
levels of depression, anxiety and craving which almost disappeared after nearly 3 
weeks of withdrawal, whereas these clinical signs persisted in abstinent patients with 
concurrent microbial changes (de Timary et al., 2015; Leclercq et al., 2014b, 2012). 
This intriguing observation poses the question of whether the gut microbiome 
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composition could represent a biological marker of the vulnerability to develop AUD. 
Intriguingly, we report here, for the first time to the best of our knowledge, that many of 
the biobehavioral traits associated with a loss of control-prone phenotype, without heavy 
ethanol intoxication, correlate with microbiome composition. 
It is important to note that rats in this study underwent a 3-month period of abstinence 
before microbiome analyses in caecal contents and measures of mRNA in striatal areas 
of the brain. Therefore, measures reported here do not correlate with acute ethanol 
intoxication, but rather reflect long-lasting behavioral traits, i.e. the loss of control-prone 
phenotype observed in vulnerable rats versus the temperate behavioral profile reported 
in resilient animals. Our observations are in line with those reported above regarding a 
role for microbiota composition in negative reinforcement processes driving alcohol 
consumption  (de Timary et al., 2017, 2015). However, our study presents two 
limitations that need to be addressed in the near future, 1) fecal analyses before alcohol 
training would inform on pre-existing compositional differences in microbiome in rats 
developing uncontrolled alcohol seeking behavior over time, and 2) measures of 
peripheral markers would inform on systemic inflammation occurring in vulnerable rats 
compared to resilient ones. Nevertheless, this is the first study reporting that 
microbiome composition is associated to addictive behavioral traits as opposed to acute 
effects of drug exposure. 
Here we took advantage of normal variation in behavioural traits relevant to addiction 
to stratify an outbred cohort into either Vulnerable or Resilient. Not surprisingly, rats with 
impulsive traits were at higher risk of developing AUD, and this pre-existing impulsive 
trait shifted towards a compulsive-like behavior after extensive instrumental 
conditioning, associated with increased relapse rates after a period of protracted 
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abstinence. Of particular relevance, these animals still exhibited higher mRNA 
expression of D1 receptors and lower mRNA expression of D2 receptor within the 
dorsal striatum after a prolonged period of abstinence. The striatum is mainly composed 
of medium spiny neurons (MSN), typically divided into those expressing dopamine 
receptor D1, forming the so-called direct pathway, and those expressing D2 receptor 
(indirect pathway). Whereas D1-MSNs mediate reinforcement and reward, D2-MSNs 
have been associated with aversion and avoidance. A current consensus suggest that 
D1-MSNs may facilitate the selection of rewarding actions encoded in the cortex, while 
D2-MSNs may help to suppress cortical patterns that encode maladaptive or non-
rewarding actions. Therefore, positive reinforcement learning would be modulated by 
signaling within the D1 direct pathway while negative reinforcement learning would be 
modulated by signaling within the D2 indirect pathway (Cox et al., 2015; Soares-Cunha 
et al., 2016; Volkow et al., 2013). As a consequence, it is postulated that dopamine-
related impulsive phenotype partly relies on impaired negative feedback learning 
(Dagher and Robbins, 2009). Functionally, in humans, the A1 (T) allele of the dopamine 
D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) TaqIA 
(rs1800497) single nucleotide polymorphism has been associated with reduced striatal 
D2 receptor availability (Eisenstein et al., 2016), and a recent large-scale meta-analysis 
confirmed the association between the ANKK1/DRD2 Taq1A polymorphism and 
alcoholism (Wang et al., 2013). Therefore, the lower expression of striatal D2 receptors, 
concomitant with higher expression of D1 receptors, in Vulnerable rats long after their 
last alcohol consumption confirms the construct validity of our model, and questions on 
the significance of those persistent brain adaptations occurring concomitantly with gut 
microbiota composition. 
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The most profound correlations were seen in D2R mRNA expression corresponding 
to the inhibitory, indirect pathway. Significant correlations revealed changes in low 
abundance genera Lachnospiraceae UCG-006, Syntrophococcus, Shuttleworthia, 
Gemella, Allobaculum, uncultured rumen bacterium from Clostridiale vadinBB60 group, 
and Hydrogenoanaerobacterium associated to reductions in D2R. This novel finding 
indicates that gut microbiota composition may contribute to inhibitory innervations in 
brain circuits associated to addiction. The capability of gut microbiota to influence 
inhibitory circuits is not surprising given the fact that administration of Lactobacillus 
rhamnosus (JB-1) reduces anxious behaviour by altering cortical GABAergic 
innervations (Bravo et al., 2011).  
Many genus level bacteria in order Clostridiales, family Ruminococcaceae and 
Lachnospiraceae, were positively associated to AUD severity, and also correlated to 
decreased D2R mRNA expression. Correlations between genus level bacteria and 
addiction measures would indicate that although these genera are not significantly 
different by group, subtle variations in abundance may potentially coincide with 
differences in addictive behaviour. While such a correlation opens a debate and 
requires further investigation on the mechanism linking gut microbiota to striatal D2R 
mRNA expression, recent evidence offers a partial explanation with the demonstration 
that gut microbiota regulate microRNA expression in the amygdala and prefrontal 
cortex. In particular, antibiotic treatment was shown to decrease miR-206-3p, a miRNA 
implicated in the regulation of brain-derived neurotrophic factor, essential in synaptic 
plasticity (Hoban et al., 2017). Rare are the studies showing that altered microbiome 
impacts reward seeking behaviors, but a recent study reports that microbiome-depleted 
animals (following antibiotic treatment) exhibited an enhanced sensitivity to cocaine 
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reward (Kiraly et al., 2016) . Therefore, a link most likely exists between the microbiota, 
the brain and the vulnerability to drug abuse. Interestingly, this finding indicates that 
supplementation of these low abundance bacteria may have potential for treatment in 
AUD, but future studies are required to investigate if probiotic/prebiotic intervention 
targeting the gut-brain axis (aka. psychobiotics) is capable of reducing alcohol-seeking 
behaviors (Dinan et al., 2013; Hoban et al., 2017). 
 The lack of significant differences in microbiome composition may be due to the 3-
month abstinence period, however this wash-out period was chosen to ensure observed 
differences were not due to drug administration. Non-significant trends in altered 
microbiome composition between Vulnerable and Resilient group were seen in bacteria 
from family Ruminococcaceae and Lachnospiraceae. These findings are in line with 
alcohol studies showing reductions in bacteria from family Ruminococcaceae, increases 
in bacteria from family Lachnospiraceae, and increased alpha diversity associated to 
alcohol severity and altered intestinal permeability (Leclercq et al., 2014b; Llopis et al., 
2016). Interestingly, it has been shown in patients with hepatic encephalopathy that the 
levels of Ruminococcaceae correlate negatively to inflammation (Bajaj et al., 2012). 
Behavioral traits, such as impulsivity, predispose individuals to addiction and other 
neuropsychiatric conditions, such as Attention Deficit Hyperactivity Disorder (ADHD) 
and autism. Previous work showed that reductions in genera Instestimonas (family 
Ruminococcaceae) and Desulfovibrio (family Desulfovibrionaceae) were associated to 
gastrointestinal dysfunction, altered metabolism, as well as anti-social, anxious, and 
compulsive behaviors in a mouse model of autism (Golubeva et al., 2017). 
With current pharmacotherapies largely unsatisfactory, discovering novel alternatives 
to prevent AUD becomes a priority. Hence, identifying biological markers predicting 
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vulnerability to develop excessive alcohol consumption may lead to a real improvement 
of clinical care. In this study, we report that gut microbiome composition is associated 
with specific “at risk” behavioral traits in a translationally relevant model of alcohol use 
disorder.  These preclinical observations open a debate on the possible role of gut 
microbiome in predisposing individuals to alcohol use disorder and offers a perspective 
on understanding alcohol addiction the etiology of which remains partially unknown. 
While addressing addiction-related associations to gut microbiome composition is 
probably not a panacea, it offers itself as an important underappreciated additional 
component in favor of better identifying those at risks of losing control over their alcohol 
intake.  
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Legends to figures 
 
Figure 1: Identification of rats at risk of alcohol use disorder. (A) Flowchart of the 
experimental procedure. (B) Distribution of the 59 rats: 26 rats in the 0 criterion group, 
14 rats in the 1 criterion group, 12 rats in the 2 criteria group, 7 rats in the 3 criteria 
group. (C) Persistence in lever pressing during no-drug period: One-way ANOVA 
showed a significant difference (F3,55 = 17.436, p < 0.0001). Post hoc Bonferroni’s test 
revealed that the 3crit rats exhibited higher lever presses compared to the 0Crit 
(p < 0.0001), the 1Crit p=0.0048) but not as compared to the 2Crit rats (p=0.96). The 
2Crit rats differed from 0Crit rats (p < 0.001) and 1Crit rats (p = 0.0012). The 0 and 1 
criterion rats had similar performances (p = 0.149). * Significant compared to 0Crit and 
1Crit rats. (D) Motivation on progressive ratio: One-way ANOVA showed a statistically 
significant difference (F3,55 = 23.23, p < 0.0001). Post hoc Bonferroni’s tests revealed 
that the 3Crit rats displayed an increased motivation for ethanol seeking compared to 
0crit rats (p < 0.0001), and 1Crit rats (p=0.0018) but not as compared to the 2Crit rats 
(p=0.62). The 2Crit rats displayed a higher breaking point compared to 0Crit (p < 0.001) 
and 1Crit rats (p = 0.002). The 1crit rats exhibited a higher breaking point compared to 
the 0Crit rats (p = 0.001). * Significant compared to 0Crit and 1Crit rats. # Significant 
compared to 0Crit rats. (E) Alcohol seeking in presence of shock: One-way ANOVA 
showed a statistically significant difference (F3,55 = 22.55, p < 0.0001). Post hoc 
Bonferroni’s tests revealed that 3crit rats accepted more shocks than 2Crit (<0.0001), 
1Crit (p < 0.0001) and 0Crit rats (p = 0.002). Whereas 2Crit rats were not different from 
1Crit rats (p = 0.372), they exhibited a higher resistance to punishment as compared to 
the 0Crit rats (p = 0.002). Finally, 1Crit rats had higher lever presses than 0Crit rats 
(p=0.0002). # Significant compared to 0Crit rats. @ Significant compared to 0Crit, 1Crit 
and 2Crit rats. (F) Addiction Score:  A one-way ANOVA revealed a significant difference 
(F3,55 = 67.20, p<0.0001). A post hoc Bonferroni’s test showed the each group was 
significantly different from the other groups. This shows that the addiction score is highly 
representative of the three criteria scores. #Significant compared to 0Crit rats. 
*Significant compared to 0Crit and 1Crit rats. @Significant compared to 0Crit, 1Crit and 
2Crit rats. (G) Reinstatement: A one-way ANOVA revealed a significant difference 
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between the groups (F3,55 = 6.13, p=0.0012). A post hoc Bonferroni’s test showed that 
the 2Crit and 3Crit rats had higher active lever presses as compared to 0Crit (p<0.01) 
and 1Crit (p<0.001). We chose to group 0Crit and 1Crit rats, labelled them as Resilient 
and grouped 2Crit and 3Crit, and labelled them as Vulnerable. * Significant compared to 
0Crit and 1Crit rats. (H) Partial grid paradigm: A two-way repeated measures ANOVA 
with repetition in one factor identified a significant group effect (F1,56 = 16.62, p<0.0001), 
a significant effect of intensity of the shock (F2,116 = 105.89, p<0.001) and but no 
interaction effect (F112,173 = 2.07, p=0.1298). (I) Effect of Baclofen on progressive ratio: 
A two-way repeated measures ANOVA with repetition in one factor identified a 
significant group effect (F1,56 = 11.09, p=0.0015),  a significant dose effect 
(F2,116 = 25.71, p<0.0001) and a significant interaction effect (F112,173 = 10.46, p<0.0001). 
A group-wise post hoc Bonferroni’s test showed that both the doses reduced the 
motivation for ethanol intake in the Vulnerable group, while only the 2 mg/kg dose had 
an effect in the Resilient group of rats. ^ Significant compared to 0 mg/kg in Vulnerable 
rats. & Significant compared to 0mg/kg in respective groups. (J) Effect of Baclofen on 
Reinstatement: A two-way repeated measures ANOVA with repetition in one factor 
identified a significant group effect (F1,55 = 9.25, p=0.0036),  a significant dose effect 
(F1,55 = 67.81, p<0.0001) and a significant interaction effect (F55,113= 7.55, p=0.008). This 
indicates that baclofen had a more pronounced effect in the Vulnerable group of rats as 
compared to Resilient rats. (K) Impulsivity on 5CSRTT: The average percentage of 
premature responses was 40.34 ± 1.64 and 47.37 ± 2.7, for Resilient and Vulnerable 
rats, respectively. An Unpaired T-test (t57 = -2.315, p=0.02) revealed that the 
Vulnerable group had a significantly higher number of premature responses as 
compared to the Resilient group. *Significant compared to Resilient rats. (L) Factor 
Analysis: All the five variables loaded on one construct (Persistence in drug seeking 
during the no-drug period: r = 0.719, Excessive motivation for alcohol seeking: r = 0.832, 
Resistance to punishment: r = 0.715, reinstatement: r = 0.658 and impulsivity: r=0.65) 
accounting for 50% of the variance, further supporting that the three addiction-like 
criteria, reinstatement and the pre-existing trait of impulsivity are measures of a single 
underlying factor. 
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Figure 2: Selection of most Resilient (grey, n=19, combining 18 0Crit and 1 1Crit rats) 
and most Vulnerable (red, n=19, combining twelve 2Crit and seven 3Crit rats) animals 
among the 59 rats screened, according to (A) Persistence in lever pressing during no-
drug period, (B) Motivation on progressive ratio schedule, (C) Alcohol seeking in presence 
of shock, (D) Addiction Score, (E) Reinstatement and (F) Response to baclofen assessed 
in a progressive ratio schedule. Significance codes:  *** p<0.001, ** p<0.01, * p<0.05. 
 
Figure 3: A posteriori analyses revealed that Vulnerable rats exhibited increased 
impulsivity (A), similar exploration in an elevated plus maze (B), increased novelty 
induced locomotion (C), similar alcohol intake after prolonged conditioning (D), increased 
D1R mRNA (E) and decreased D2R mRNA expression (F) in the dorsal striatum 
compared to Resilient rats. In bar graphs all samples are plotted as grey dots. In box-
and-whisker plots outliers are indicated with a black dot. Resilient group (grey) is plotted 
on left, Vulnerable group (red) on right. Significance codes:  *** p<0.001, ** p<0.01, * 
p<0.05. 
 
Figure 4: Microbiome Diversity. A) Alpha diversity index measures of bacterial richness 
(chao1 index and observed_species index). B) Alpha diversity index measure of 
bacterial richness and evenness (shannon index). In box-and-whisker plots outliers are 
indicated with a black dot. C) PCoA ordination plot of orthogonal taxonomic unit (OUT) 
beta diversity. Percent explained variance reported on first (x-axis) and second (y-axis) 
principal component axis. Density of cluster indicated for the y-axis (right) and x-axis 
(bottom) by group.  
 
Figure 5: Genus Level Relative Abundance. The mean of the 22 most abundant 
bacteria are plotted by group, with the inner ring representing Vulnerable and outer ring 
representing Resilient group. Legend displays bacterial name with taxonomic 
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designation at each level down to genus; bacteria are listed by order of appearance 
starting with Bacteroides (blue) at top. 
 
Figure 6: Left panel - Correlations (positive in red, negative in blue) between genus-
level bacteria (y-axis) and addiction measures (x-axis); Right panel – Log2 fold change 
ratio showing changes in Vulnerable group relative to Resilient (increases in red, 
decreases in blue) for genera corresponding to correlation heatmap (left panel). 
Abbreviations (left to right x-axis): active lever presses without ethanol (LP.woEtOH), 
active lever presses with shock (LP.wShock), progressive ratio breaking point (PR), 
addiction score (Addiction.score), criteria designation 0Crit-3Crit (Criteria), percentage 
of premature responses in 5 choice serial reaction time task (5CSRTT), percent time in 
open arm in elevate plus maze (EPM), locomotor activity in open field test (OFT), total 
ethanol consumed over 80 sessions (TotEtOH), dopamine 1 receptor mRNA expression 
(D1R), dopamine 2 receptor mRNA expression (D2R), change in progressive ratio 
breaking point between 0mg/kg dosage and 1mg/kg dosage baclofen (dPR.baclofen), 
active lever presses during reinstatement (Reinstatement). 
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Material and methods  
 
Apparatus: 
A) Self-administration (SA) chambers 
Twelve operant chambers (305 x 241 x 210 mm, Med Associates, St. Albans, Vermont, 
USA) were used for the experiment. The chambers were housed in larger sound 
attenuated cubicle, equipped with exhaust fans for air renewal, also used for masking 
the background noise. The floor was made of a grid capable of delivering electrical 
shock. Each operant panel contained two retractable levers 60 mm above the grid and 
35 mm equidistant from the midline, with a white light diode mounted 30 mm above 
each lever. Between the two levers was the delivery section which delivered 0.1mL of 
the fluid by means of a dipper. 
 
B) Chambers for testing impulsivity 
Six operant chambers (305 x 241 x 292 mm) were used for the 5-Choice Serial 
Reaction Time Task experiment (Med Associates Inc., St-Albans, Vermont, USA). Each 
chamber was enclosed in wooden cubicles equipped with an exhaust fan for ventilation. 
Each cage contained a stainless-steel grid floor spaced by 18mm, allowing waste 
collection in a removable tray containing sawdust. Front and back wall of the cage were 
in Plexiglas, while left and right wall were made of steel. Five nosepoke cavities (25x25 
mm) were located on the left side of the cage, each spaced by 25mm. A food tray 
located 20 mm above the grid was available on the right side. Nosepoke cavities and 
food tray were equipped with a light and an infrared beam to monitor activity. Each cage 
was also equipped with a house light fixed on the ceiling, and a tone device. All the 
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operant cages were linked to a common interface, and to a computer that controlled 
experimental procedures through Med Associates software (Med-PC IV). 
 
Impulsivity- 5 Choice Serial Reaction Time Task (5-CSRTT). 
Before the rats were exposed to alcohol, their impulsivity profile was ascertained by 
testing them on the 5-CSRTT. Rats were food restricted and maintained at 90% of their 
initial weight. For the whole experiment, sucrose pellets (Dustless precision pellet 45 
mg, rodent purified diet, BioServ, Frenchtown, NJ, USA) were given as a “reward” for 
correct responses.  
Rats were first trained to nose poke in the food tray to get a food pellet reward. Each 
session stopped when rats collected 50 pellets of after 30 min. 
Then, on each trial, rats were trained to nose poke first in the food tray to start a trial 
and later nose poke in one of the five holes, randomly illuminated in order to get a food 
pellet reward (recorded as a correct response). Nose poking in a different hole was 
recorded but had no consequence. Each session stopped when rats collected 40 pellets 
of after 30 min. 
The next training phase was similar to the previous ones, but a 5-sec delay preceded 
the random illumination and nose poking in a non-illuminated hole was recorded as an 
incorrect response, triggering a 5-sec time out period signalled by the illumination of the 
house light. Each session stopped when rats collected 50 pellets of after 30 min. 
Then, a 5-second tone was introduced to indicate the 5-sec delay before the random 
illumination. At the end of the tone, one of the 5 holes was briefly illuminated for 2 
seconds. Any response during the tone, i.e. before the holes being illuminated, was 
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recorded as a premature response but had no consequence. Correct and incorrect 
responses were recorded as previously explained. Absence of response during the 5 
sec post-illumination was recorded as an omission.  
Ultimately, rats were tested in the 5-CSRTT paradigm during which each premature 
response was punished by a time out of 5 seconds and the illumination of the house 
light. The correct, incorrect and omission responses were recorded as previously 
described. 
 
Premature responses were calculated as [premature responses * 100/ (correct + 
incorrect + omission + premature responses)].  
 
Anxiety-related behaviors 
Rats were tested in an Open Field and in an Elevated plus maze paradigm for 
evaluating anxiety-like behaviors after the 5-CSRTT procedure. Both experiments were 
conducted under a dim light (10-15 Lx) during the active phase. Animal tracks were 
recorded by a digital video camera mounted above the maze and connected to a 
computer running a tracking-software (ANY-maze Video Tracking System v.4.99 – 
Stoelting Co., Wood Dale, IL, USA). 
 
Open Field Test (OFT) 
Rats were placed in a round arena (140 cm of diameter, 30 cm of depth) and their motor 
and exploratory activities were monitored for 60 min.  
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Elevated Plus Maze (EPM) 
The elevated plus maze consisted of two opposite open arms (50cm L x 10cm W x 42.5cm 
H) and two opposite closed arms (50cm L x 10cm W) arranged in a cross and elevated 
50 cm above the floor.  In the center, a small platform (10cm x 10cm) gave access to all 
arms. Rats were gently placed in the center of the maze face to a close arm and their 
behavior was monitored for 5 min. The time spent on open arms was used as an index of 
anxiety. 
 
Animal’s training for alcohol self-administration  
Laboratory rodents do not voluntarily consume alcohol to intoxication, in part because of 
taste aversion. Higher levels of consumption could be achieved by masking the taste of 
alcohol with saccharine (Roberts, Heyser, & Koob, 1999), which was faded out as 
alcohol concentrations increased (Dayas, Liu, Simms, & Weiss, 2007). Rats were 
trained under a Fixed Ratio 1 - Time Out 4sec schedule of reinforcement for a total of 
105, 30-min daily sessions (25 sessions of saccharine fading + 80 sessions of ethanol 
self-administration). During these baseline conditions, pressing the right (active) lever 
delivered 0.1 mL of ethanol (10%w/v in tap water, prepared from a 94% (vol/vol) ethanol 
solution) in the delivery section and illuminated the diode above the active lever. The left 
lever was inactive, presses were recorded but had no consequence. 
 
 
 
 6 
Screening for addiction-like behavior 
 
Between test sessions aiming at scoring addiction-like behaviors (3 daily consecutive 
sessions each time), rats underwent 2 consecutive sessions of basic training during 
which they were trained again under the same baseline conditions (Jadhav et al., 2017). 
 
A) Inability to abstain during a signaled period of reward unavailability 
 
Rats underwent 3 daily consecutive sessions; each one consisted of an 8 minute-period 
of reward availability, followed by a 4 minute-period of signaled unavailability. Repeated 
three times, this sequence resulted in a total of 36 min. The period of unavailability was 
signaled by lighting up the self-administration chamber house light and interrupting the 
cubicle fan. The light diode above the active lever remained off after lever presses, and 
alcohol was not delivered. The average number of active lever presses during the 
signaled unavailability periods indicated the persistence in drug seeking during the no 
drug period. 
 
B) High motivation for alcohol seeking 
 
Rats were required to progressively increase the number of active lever presses 
between two successive rewards based on the progression sequence given by the 
following formula: response ratio = (5e(reward× 0.2)) − 5. Hence, the progressive-ratio 
schedule followed the progression: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 
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118, etc. Each session lasted 90 min, or automatically shut down following 20 
consecutive minutes of inactivity on the active lever. The maximal number of active  
lever presses performed to reach the final ratio was defined as the breakpoint, a value 
reflecting animals’ motivation to get the reward. The breaking point across 3 
consecutive daily sessions was averaged and considered as marker of motivation for 
alcohol seeking. 
 
C) Resistance to punishment 
 
In this paradigm, each lever press delivered 0.1 mL of 10% w/v ethanol by means of a 
dipper, followed by mild electric foot shocks (0.22 mA for 0.5 second) through the grid of 
the SA chamber when the dipper retracted. This was conducted for 3 consecutive daily 
sessions, and the average number of active lever presses across these 3 consecutive 
trials was considered as a marker of resistance to punishment, reflecting a compulsive 
reward seeking and taking behavior. 
 
Selection of resilient rats for microbiome analysis 
We intended to select the rats falling at the lower end of the resilient group, meaning not 
only they would have 0 criterion, but most importantly their lever pressing behavior was 
constantly low (as compared to rats near the inclusion condition for each criterion). 
Therefore, we took the data of 40 Resilient rats and identified which rats fall in the lower 
50 percentile for each of the 3 behaviours (yellow boxes in the table). Then we selected 
those rats which fell in the lowest 50 percentile for 2 or 3 behaviours (red boxes in 
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table). Most of the rats selected by this method belonged to the original 0 Criterion 
group, except 2 rats which belonged to the 1 Crit group (rat#51 and #54). However, one 
of this 1 Crit rat had to be isolated in a single cage towards the end of the experiment 
since it displayed aggressive behaviour. Hence, this rat was not selected and thus we 
ended up with 18 0 Crit rats and one, 1Crit rat of the resilient group. We considered 
rat#51 (1Crit) had to be included in the selection of resilient rats for microbiome analysis 
given its limited lever pressing behavior in general, even though it reached the inclusion 
criterion for the progressive ratio experiment. 
Rats A B C Nb of Criterion 
1 5,67 27,33 10,00 0 
3 9,33 40,33 7,67 0 
4 11,67 37,67 3,67 1 
5 4,33 28,67 8,00 0 
6 5,67 21,00 5,33 0 
7 3,33 28,33 6,00 0 
13 5,33 35,00 3,00 0 
15 8,33 28,33 11,00 0 
16 4,67 39,00 1,67 0 
17 9,33 28,00 9,00 0 
18 2,33 23,67 3,33 0 
19 8,00 16,00 5,67 0 
20 9,00 17,67 12,33 0 
21 11,00 31,33 20,33 1 
22 8,67 26,33 5,00 0 
23 6,00 34,33 5,33 0 
24 6,00 15,33 3,67 0 
26 5,00 30,00 24,33 1 
28 15,00 37,67 20,67 1 
30 6,67 40,67 24,33 1 
35 9,00 35,00 21,67 1 
36 7,67 46,33 8,33 1 
38 6,00 32,33 36,67 1 
39 8,33 40,33 50,67 1 
42 7,67 25,67 10,67 0 
44 7,33 19,67 10,00 0 
45 8,00 28,00 4,67 0 
46 2,33 14,33 4,00 0 
47 2,00 21,67 4,00 0 
48 6,00 34,00 6,33 0 
49 5,00 24,00 9,33 0 
50 6,67 31,00 5,00 0 
51 3,67 46,33 4,67 1 
53 10,00 25,67 12,67 1 
54 5,67 22,33 38,67 1 
55 6,67 25,67 5,33 0 
56 3,33 32,00 13,00 0 
57 6,00 19,67 8,67 0 
59 9,67 37,67 11,00 1 
60 8,67 57,67 19,67 1 
     
   Rat falling in the lowest 50 percentile for this criterion 
   All rats selected for microbiota analysis, but #54 
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Partial grid paradigm 
In this paradigm, the rats must press the active lever once to gain access to 0.1mL of 
10% ethanol. The grid was divided into thirds, 2/3rd of the grid closest to the lever and 
delivery section delivered shock continuously, 1/3rd of the grid farthest from the lever 
was not electrified. Test rats had to bear shock before and during lever presses to 
administer ethanol, a condition defined as a conflict model (Barnea-Ygael et al., 2012; 
Cooper et al., 2007). The rats were exposed to this paradigm for 30 mins for 3 sessions 
of increasing shock strength of 0.1mA, 0.15mA and 0.2mA. The number of active lever 
presses was recorded. 
 
Reinstatement paradigm 
At the end of all behavioral paradigm tests, rats were subjected to approximately 45 
days of forced abstinence after which they were re-exposed to the self-administration 
chambers. The rats were given access to the same conditions as the training sessions, 
where one active lever presses resulted in lighting up of the cue light above the lever, 
however ethanol was not delivered. The number of active lever presses during this 
period of 30 minutes measured propensity to relapse. 
 
Results 
Persistence in lever pressing during the no-drug period 
The mean number of lever presses for each group were 6.03 ± 0.43 (0Crit), 8.43 ± 0.79 
(1Crit), 12.28 ± 1.16 (2Crit) and 12.33 ± 0.93 (3Crit), respectively. A one-way ANOVA 
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showed a significant difference between groups (F3,55 = 17.436, p < 0.0001). Post hoc 
Bonferroni’s test revealed that, during the no-drug period, the 3Crit rats exhibited higher 
lever presses compared to 0Crit (p < 0.0001) and 1Crit (p<0.01) groups, but not 2Crit 
(p>0.05). The 2 criteria rats differed from 0 criteria rats (p < 0.001) and 1 criteria rats 
(p <0.01). The 0 and 1 criterion rats had similar performances (p>0.05). 
Increased motivation for alcohol seeking and drinking in an effortful condition 
The average breaking points for the four groups were 26.34 ± 1.37 (0Crit), 37.21 ± 2.43 
(1Crit), 49.33 ± 4.06 (2Crit) and 51.57 ± 3.27 (3Crit). One-way ANOVA showed a 
statistically significant difference among the groups (F3,55 = 23.23, p < 0.0001). Post 
hoc Bonferroni’s tests revealed that the 3Crit rats displayed an increased motivation for 
ethanol seeking compared to 0Crit (p < 0.0001) and 1crit (p<0.01) groups, but not 
compared to 2Crit (p>0.05). The 2Crit rats displayed a higher breaking point compared 
to 0Crit (p < 0.001) and 1Crit (p<0.01) groups. Finally, even the 1Crit rats exhibited a 
higher breaking point compared to the 0Crit rats (p < 0.001). 
 
Resistance to punishment 
The average lever presses for each group when each lever press was associated with a 
mild shock were 6.84 ± 0.6 (0Crit), 21.23 ± 3.6 (1Crit), 20.36 ± 3.58 (2Crit) and 
43.62 ± 7.28 (3Crit) (Fig. 2D). One-way ANOVA showed a statistically significant 
difference among the groups (F3,55 = 22.55, p < 0.0001). Post hoc Bonferroni’s tests 
that 3Crit rats accepted more shocks than 2Crit (p<0.0001), 1Crit (p < 0.0001), and 0Crit 
rats (p<0.01). The 2Crit rats had higher lever presses as compared to 0Crit rats 
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(p<0.001), but not 1Crit rats (p>0.05). Finally, even the 1Crit rats had higher lever 
presses than 0Crit rats (p<0.001). 
 
Addiction score and vulnerability to relapse after protracted abstinence 
The scores for the four groups were -2.06 ± 0.16 (0Crit), 0.23 ± 0.28 (1Crit), 2.04 ± 0.4 
(2Crit) and 3.68 ± 0.6 (3Crit). A one-way ANOVA revealed a significant difference 
between groups (F3,55 = 67.20, p<0.0001). A post hoc Bonferroni’s test showed that 
each group was significantly different every other group. Pearson’s correlation analysis 
showed that the three criteria scores were highly correlated with the addiction score 
(persistence in drug seeking in absence of alcohol [r=0.77, p<0.0001], excessive 
motivation for alcohol seeking and drinking [r= 0.836, p<0.0001] and resistance to 
punishment [r=0.536, p<0.0001]). 
Rats were subjected to a 45-day period of forced abstinence, followed by which the rats 
were exposed to the reinstatement paradigm. A one-way ANOVA revealed a significant 
difference between criterion groups (F3,55=6.13, p<0.01). A post hoc Bonferonni’s test 
showed that the 2Crit and 3Crit rats had higher active lever presses compared to 0Crit 
(p<0.01) and 1Crit (p<0.001).  
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Once the four groups were identified, we analyzed their lever pressing behavior during 
the training sessions. 
 Session 6-10 Session 21-25 Session 41-45 Session76-80 
0Crit 39.20 ± 3.59 30.26 ± 2.10 30.56 ± 1.88 43.67 ± 2.74 
1Crit 41.40 ± 4.48 37.77 ± 2.58 44.82 ± 4.64 46.31 ± 3.08 
2Crit 35.25 ± 2.95 37.86 ± 3.59 37.41 ± 3.62 49.32 ± 4.78 
3Crit 41.05 ± 3.44 41.17 ± 3.16 50.40 ± 3.69 64.46 ± 2.94 
Table1: Evolution of lever pressing behavior over the course of the operant conditioning 
A two-way repeated measures ANOVA with repetition in one factor identified a 
significant group effect (F3,55 = 4.93, p=0.0042), a significant effect of number of 
training sessions (F3,177 = 14.03, p<0.001) and a significant effect of group X number 
of training session interaction (F9,165 = 2.05, p=0.0361). A post hoc Bonferroni’s test to 
compare the difference between subjects at a particular training session revealed that 
all the groups were comparable to each other at training session 6-10 and training 
sessions 21-25. The number of lever presses between groups were significantly 
different at session 41-45 (0crit vs 3crit, p=0.0004). Also, the number of lever presses 
between groups were significantly different at session 76-80 (0crit vs 3 Crit, p=0.0007 
and 1crit vs 3crit, p= 0.0053). A post hoc Bonferroni’s test to compare the differences 
within a group of rats, showed that for all the groups the active lever presses at session 
76-80 were significantly higher than the lever presses at session 6-10 (p<0.01) and at 
session 21-25 (p<0.01). This shows at all the groups showed a steady increase in their 
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lever pressing behavior as compared to their baseline lever pressing behavior. 
However, since the interaction effect is significant, it shows that magnitude of change 
was higher in the 2crit and 3crit rats. 
 
 
Average active 
lever presses for 
saccharine only 
Average active 
lever presses for 
ethanol only 
(Session 6-10) 
Average active 
lever presses for 
ethanol only 
(Session 41-45) 
Average active 
lever presses for 
ethanol only 
(Session 76-80) 
Persistence in 
drug seeking 
during the no-drug 
period 
-0.04 -0.085 0.23 0.206 
Excessive 
motivation for 
alcohol seeking 
and drinking 
0.126 -0.013 0.497* 0.446* 
Resistance to 
punishment 
0.192 0.062 0.536* 0.27* 
Table 2: *p < 0.05 Significant using Pearson’s correlational analysis (2 tailed). 
 
One argument against the model could be that some rats are inherently good at 
pressing the lever and the final output observed with the 3 behaviours reflects their 
motor abilities and not their conditioning for lever pressing for alcohol. Hence, we ran a 
correlational analysis between the three criteria scores used to define the addiction 
vulnerability and the lever presses for saccharine and for ethanol (at 3 time points: 
session 6-10, session 41-45 and session 76-80). As can be seen from the table 2, the 
lever presses for saccharine were not correlated with the three criteria scores. Similarly, 
the lever pressing for ethanol at the beginning of the training did not correlate with the 
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three criteria scores. The persistence in lever pressing during no-drug periods never 
correlated with the lever pressing at any time points. The motivation and resistance to 
punishment started showing significant correlations with the lever pressing for ethanol 
only after prolonged training.  
 
Effect of Baclofen 
Baclofen, a GABA-B receptor agonist, was tested on the progressive ratio paradigm to 
determine whether it could decrease the motivation for ethanol (Figure 1I). Two doses 
of baclofen were tested (1mg/kg and 2 mg/kg).  A two-way repeated measures ANOVA 
with repetition in one factor identified a significant group effect (F1,56 = 11.09, p<0.01), 
a significant effect of dosage (F2,116 = 25.71, p<0.0001) and a significant interaction 
effect (F112,173 = 10.46, p<0.0001). A group-wise post hoc Bonferroni’s test showed 
that both the doses of baclofen reduced ethanol intake in the Vulnerable group, while 
only the 2 mg/kg dose had an effect in the Resilient group. This observation is line with 
previous reports indicating that the reinforcing and motivational properties of alcohol in 
different lines of alcohol-preferring rats are differentially sensitive to treatment with 
baclofen (Maccioni et al., 2012). 
Additionally, the effect of baclofen in the reinstatement paradigm was tested using the 
more effective 2mg/kg dosage (Figure 1J). A two-way repeated measures ANOVA with 
repetition in one factor identified a significant group effect (F1,55 = 9.25, p<0.01), a 
significant effect of intensity of dose of baclofen (F1,55 = 67.81, p<0.0001) and a 
significant interaction effect (F55,113 = 7.55, p<0.01).  
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Factor analysis-figure 
A factor analysis was conducted for the three addiction-like criteria, reinstatement and 
impulsivity to determine whether they loaded on the same underlying construct (Figure 
1L). The eigenvalue was kept as 1. The sampling adequacy score were also all around 
0.75 as measured by the KMO test (Persistence in drug seeking during the no-drug 
period: 0.768, Excessive motivation for alcohol seeking: 0.732, Resistance to 
punishment: 0.793, reinstatement: = 0.786 and impulsivity: 0.802) which indicates that 
five variables included are suited for testing factor analysis. The five included variables 
loaded on one construct accounting for 50% of the variance, further supporting that the 
three addiction-like criteria, reinstatement and the preexisting trait of impulsivity are 
measures of a single underlying factor: 
- Persistence in drug seeking during the no-drug period: r = 0.719 
- Excessive motivation for alcohol seeking: r = 0.832 
- Resistance to punishment: r = 0.715 
- Reinstatement: r = 0.658  
- Impulsivity: r=0.65  
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Microbiome and Behavior Significant Correlations    RAW Bayesian 
Taxa Behavior Category rho P value Q value 
Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacteriaceae.uncultured PR AUD Behaviour -0.5781 0.000144 0.012371 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Intestinimonas LP.wShock AUD Behaviour 0.574573 0.000162 0.012371 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Shuttleworthia TotEtOH Behaviour -0.54853 0.000363 0.018531 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.006 D2R Dorsal Striatum 
mRNA 
-0.78571 0.000516 0.019771 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella LP.wShock AUD Behaviour -0.52572 0.0007 0.021434 
Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacteriaceae.uncultured Addiction.score AUD Severity -0.47959 0.002313 0.044387 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Anaerofilum Reinstatement Relapse 
Behaviour 
-0.47949 0.002319 0.044387 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.005 LP.woEtOH AUD Behaviour 0.482393 0.002161 0.044387 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen
.bacterium 
PR AUD Behaviour 0.470505 0.002873 0.048879 
Proteobacteria.Deltaproteobacteria.Desulfovibrionales.Desulfovibrionaceae.Desulf
ovibrio 
LP.woEtOH AUD Behaviour -0.45808 0.003828 0.054802 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Intestinimonas Addiction.score AUD Severity 0.456833 0.003937 0.054802 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.007 OFT Behaviour -0.44425 0.005877 0.058619 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella Criteria AUD Severity -0.44089 0.005596 0.058619 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella PR AUD Behaviour -0.43581 0.006239 0.058619 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella Addiction.score AUD Severity -0.4305 0.006977 0.058619 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Anaerofilum EPM Behaviour -0.42855 0.00649 0.058619 
Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacteriaceae.uncultured Criteria AUD Severity -0.42137 0.008422 0.058619 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Intestinimonas Criteria AUD Severity 0.422197 0.008281 0.058619 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen
.bacterium 
Criteria AUD Severity 0.422541 0.008223 0.058619 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.uncultured LP.wShock AUD Behaviour 0.423894 0.007999 0.058619 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.uncultured Addiction.score AUD Severity 0.430791 0.006934 0.058619 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.uncultured LP.woEtOH AUD Behaviour 0.434307 0.00644 0.058619 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.006 EPM Behaviour 0.410446 0.00945 0.062917 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Intestinimonas PR AUD Behaviour 0.41265 0.010034 0.063963 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Shuttleworthia D2R Dorsal Striatum 
mRNA 
0.635714 0.010861 0.063963 
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Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Syntrophococcus D2R Dorsal Striatum 
mRNA 
0.635714 0.010861 0.063963 
Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacteriaceae.uncultured LP.wShock AUD Behaviour -0.40035 0.012751 0.069734 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.uncultured 5CSRTT Behaviour 0.395725 0.012645 0.069734 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Eubacterium.coprostanoligen
es.group 
OFT Behaviour -0.40161 0.013748 0.072591 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella D1R Dorsal Striatum 
mRNA 
-0.61419 0.014854 0.075819 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen
.bacterium 
LP.woEtOH AUD Behaviour 0.38807 0.016062 0.079338 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Hydrogenoanaerobacterium LP.wShock AUD Behaviour -0.37932 0.018838 0.083461 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen
.bacterium 
Addiction.score AUD Severity 0.378903 0.01898 0.083461 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.006 LP.wShock AUD Behaviour 0.38064 0.018396 0.083461 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella D2R Dorsal Striatum 
mRNA 
0.595854 0.019077 0.083461 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella TotEtOH Behaviour -0.37384 0.020773 0.083706 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Eubacterium.oxidoreducens.gr
oup 
LP.woEtOH AUD Behaviour 0.375267 0.020255 0.083706 
Firmicutes.Erysipelotrichia.Erysipelotrichales.Erysipelotrichaceae.Allobaculum D2R Dorsal Striatum 
mRNA 
0.591271 0.020263 0.083706 
Firmicutes.Negativicutes.Selenomonadales.Veillonellaceae.Veillonella D1R Dorsal Striatum 
mRNA 
-0.58557 0.021817 0.084913 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Hydrogenoanaerobacterium D1R Dorsal Striatum 
mRNA 
-0.58352 0.022399 0.084913 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen
.bacterium 
D2R Dorsal Striatum 
mRNA 
-0.57857 0.023847 0.084913 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Papillibacter D1R Dorsal Striatum 
mRNA 
-0.57143 0.026063 0.084913 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.007 Reinstatement Relapse 
Behaviour 
-0.36639 0.023671 0.084913 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Hydrogenoanaerobacterium Addiction.score AUD Severity -0.36518 0.02417 0.084913 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.006 Criteria AUD Severity 0.362255 0.025416 0.084913 
Firmicutes.Erysipelotrichia.Erysipelotrichales.Erysipelotrichaceae.Erysipelotrichace
ae.UCG.003 
D2R Dorsal Striatum 
mRNA 
0.571726 0.025968 0.084913 
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Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Hydrogenoanaerobacterium D2R Dorsal Striatum 
mRNA 
0.575986 0.024632 0.084913 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.NK4B4.group LP.woEtOH AUD Behaviour 0.359166 0.02679 0.085463 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Eubacterium.coprostanoligen
es.group 
5CSRTT Behaviour -0.35044 0.02873 0.089202 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.005 5CSRTT Behaviour 0.349628 0.029127 0.089202 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Papillibacter EPM Behaviour 0.346981 0.030454 0.091437 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Anaerofilum D2R Dorsal Striatum 
mRNA 
0.553571 0.032287 0.095076 
 
Table 3: Significant correlations between microbiome and behavior for Figure 6 of manuscript.  
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Significant correlated genera presence and abundance Relative Abundance (%) All Samples Resilient Vulnerable 
Taxa Median Mean Presence Presence% Presence Presence 
Proteobacteria.Deltaproteobacteria.Desulfovibrionales.Desulfovibrionaceae.Desulfovibrio 1.076% 1.569% 38 100.0% 19 19 
Firmicutes.Negativicutes.Selenomonadales.Veillonellaceae.Veillonella 0.000% 0.012% 10 26.3% 7 3 
Firmicutes.Erysipelotrichia.Erysipelotrichales.Erysipelotrichaceae.Erysipelotrichaceae.UCG.003 0.002% 0.005% 26 68.4% 13 13 
Firmicutes.Erysipelotrichia.Erysipelotrichales.Erysipelotrichaceae.Allobaculum 0.000% 0.010% 19 50.0% 11 8 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Papillibacter 0.123% 0.130% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Intestinimonas 0.103% 0.108% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Hydrogenoanaerobacterium 0.000% 0.001% 18 47.4% 9 9 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Eubacterium.coprostanoligenes.group 2.351% 2.893% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Anaerofilum 0.006% 0.007% 35 92.1% 19 16 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.uncultured 4.017% 4.539% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Syntrophococcus 0.006% 0.010% 35 92.1% 18 17 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Shuttleworthia 0.014% 0.028% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.007 0.001% 0.002% 24 63.2% 12 12 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.006 0.077% 0.083% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.UCG.005 0.142% 0.178% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Lachnospiraceae.NK4B4.group 0.016% 0.025% 37 97.4% 18 19 
Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Eubacterium.oxidoreducens.group 0.125% 0.155% 38 100.0% 19 19 
Firmicutes.Clostridia.Clostridiales.Clostridiales.vadinBB60.group.uncultured.rumen.bacterium 0.009% 0.018% 34 89.5% 15 19 
Firmicutes.Bacilli.Bacillales.Family.XI.Gemella 0.000% 0.001% 9 23.7% 8 1 
Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacteriaceae.uncultured 0.109% 0.121% 38 100.0% 19 19 
 
Table 4: Relative abundance and sample presence of genus level bacteria shown in correlation results - Figure 6 of manuscript.   
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Taxa Behavior rho P value Q value 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI LP.wShock -0.52572 0.0007 0.031114 
D_0__Bacteria.D_1__Proteobacteria.D_2__Deltaproteobacteria.D_3__Desulfovibrionales. 
D_4__Desulfovibrionaceae LP.woEtOH -0.46947 0.002944 0.079496 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__4.15.D_4__uncultured.bacterium TotEtOH 0.443216 0.005322 0.121537 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI Criteria -0.44089 0.005596 0.124331 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI PR -0.43581 0.006239 0.132315 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI 
Addiction 
score -0.4305 0.006976 0.140972 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI D1.mRNA -0.61419 0.014854 0.222395 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridia.D_3__Clostridiales.D_4__Peptococcaceae OFT -0.39562 0.016925 0.240916 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridia.D_3__Clostridiales.D_4__Defluviitaleaceae 
dPR. 
baclofen 0.383965 0.017318 0.244105 
D_0__Bacteria.D_1__Firmicutes.D_2__Negativicutes.D_3__Selenomonadales.D_4__Acidaminococcaceae 
Addiction 
score -0.38047 0.018452 0.254555 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI D2.mRNA 0.595854 0.019077 0.255258 
 
Table 5: Family level correlations to behavioral measures. Green highlights indicate correlations that pass FDR with a q value set to 0.25.    
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Relative 
Abundance (%) All Samples Resilient Vulnerable 
Taxa Median Mean Presence Presence% Presence  Presence  
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__Bacillales.D_4__Family.XI 0.000% 0.001% 9 23.684% 8 1 
D_0__Bacteria.D_1__Proteobacteria.D_2__Deltaproteobacteria.D_3__Desulfovibrionales
.D_4__Desulfovibrionaceae 1.189% 1.714% 38 100.000% 19 19 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D_3__4.15.D_4__uncultured.bacterium 0.000% 0.001% 10 26.316% 3 7 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridia.D_3__Clostridiales.D_4__Peptococcace
ae 0.737% 0.752% 38 100.000% 19 19 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridia.D_3__Clostridiales.D_4__Defluviitaleace
ae 0.004% 0.004% 32 84.211% 15 17 
 
Table 6: Relative abundance and sample presence of family level bacteria shown in correlation results - Table 5 above.   
 
